MODERN MANAGEMENT OF PARKINSON’S DISEASE – PHARMACOLOGICAL, SURGICAL, AND NEUROPROTECTIVE APPROACHES

Authors

  • Khakimov M.N. Author

Keywords:

Keywords: Parkinson’s disease, levodopa, deep brain stimulation, dopamine agonists, neuroprotection, stem cell therapy, GDNF.

Abstract

Abstract: The management of Parkinson’s disease has evolved from solely symptomatic treatment to a multifaceted strategy combining pharmacological therapy, surgical interventions, and multidisciplinary care. This article reviews current treatment options, including emerging neuroprotective and disease-modifying strategies.

References

1. Olanow CW, Stocchi F. Levodopa: current status. Journal of Neurology. 2018;265:1–12.

2. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation. New England Journal of Medicine. 2006;355(9):896–908.

3. Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease. JAMA. 2014;311(16):1670–1683.

4. Barker RA, Björklund A. Parkinson’s disease: cell therapy. Cold Spring Harbor Perspectives in Medicine. 2020;10(7):a035206.

5. Oertel W, Schulz JB. Current and experimental treatments of Parkinson disease. Lancet Neurology. 2016;15(4):452–466.

Published

2025-12-10

How to Cite

Khakimov M.N. (2025). MODERN MANAGEMENT OF PARKINSON’S DISEASE – PHARMACOLOGICAL, SURGICAL, AND NEUROPROTECTIVE APPROACHES. JOURNAL OF NEW CENTURY INNOVATIONS, 90(2), 104-105. https://journalss.org/index.php/new/article/view/9283